The 130-kDa and 180-kDa replication proteins of Tomato mosaic virus (ToMV) covalently bind guanylate and transfer it to the 5 0 end of RNA to form a cap. We found that guanylylation-competent ToMV replication proteins are in membrane-bound, disulfide-linked complexes. Guanylylation-competent replication proteins of Brome mosaic virus and Cucumber mosaic virus behaved similarly. To investigate the roles of disulfide bonding in the functioning of ToMV replication proteins, each of the 19 cysteine residues in the 130-kDa protein was replaced by a serine residue. Interestingly, three mutant proteins (C179S, C186S and C581S) failed not only to be guanylylated, but also to bind to the replication template and membranes. These mutants could trans-complement viral RNA replication. Considering that ToMV replication proteins recognize the replication templates, bind membranes, and are guanylylated in the cytoplasm that provides a reducing condition, we discuss the roles of cysteine residues and disulfide bonds in ToMV RNA replication.
Introduction
Many animal viruses of medical and veterinary importance and most plant viruses are positive-strand RNA viruses. These viruses have single-stranded, messenger-sense RNA genomes in virions. After invasion of virions into host cells, their genomic RNAs are released from virions into the cytoplasm and translated to produce proteins that function in RNA replication. These replication proteins selectively recruit their genomic RNAs onto host intracellular membranes, and then synthesize complementary (negative-strand) RNAs. Progeny genomic RNAs (and for some viruses, subgenomic RNAs) are synthesized via the negative-strand RNAs. The negative-strand RNA is sequestered in replication protein-containing, membrane-bound complexes that are called ''replication complexes'' (Ahlquist, 2006; den Boon and Ahlquist, 2010; den Boon et al., 2010) .
The alphavirus-like superfamily includes animal viruses such as Hepatitis E virus and Semliki forest virus, and many plant viruses including Tobacco mosaic virus (TMV), Brome mosaic virus (BMV), and Cucumber mosaic virus (CMV) (Scholthof et al., 2011; van der Heijden and Bol, 2002) . Their genomic RNAs have the 5 0 -cap and encode replication proteins that contain methyltransferase-like, helicase-like, and polymerase-like domains and direct 5 0 -capping and viral RNA synthesis (van der Heijden and Bol, 2002) . The genus
Tobamovirus includes TMV and Tomato mosaic virus (ToMV), and their genomic RNAs encode a replication protein of approximately 130 kDa (130K protein) and its read-through product of 180 kDa (180K protein), a cell-to-cell movement protein, and a coat protein (Ishikawa and Okada, 2004) (Fig. 1A) . The 130K protein contains a methyltransferase domain in its N-terminal region and transfers a methyl group from S-adenosyl methionine (AdoMet) to the N7 position of GTP, forms a covalent complex with m 7 GMP (Merits et al., 1999) , and transfers the m 7 GMP moiety to 5 0 -diphosphate terminus of nascent progeny RNA to generate the 5 0 -cap structure (m 7 GpppGUAUU-) (Nishikiori et al., 2011) . The 130K protein also contains a helicase domain in its C-terminal region; and hydrolyzes ribonucleoside triphosphates and unwinds double-stranded RNA through hydrolysis of ATP (Goregaoker and Culver, 2003; Nishikiori et al., 2012; Xiang et al., 2012) . The helicase domain-containing polypeptides interact with themselves in yeast and in vitro (Goregaoker and Culver, 2003; Goregaoker et al., 2001) . The 180K protein contains a polymerase-like domain in its C-terminal readthrough region, and shows RNA-dependent RNA polymerase (RdRp) activity (Nishikiori et al., 2006) . Tobamovirus replication proteins are multifunctional and serves in the process of RNA replication, as well as in suppression of RNA silencing and other host defenses (Ishibashi et al., 2010) . A fraction of the tobamovirus replication proteins co-translationally binds to the genomic RNA to form a ribonucleoprotein complex, named the pre-membrane-targeting complex (PMTC), which is targeted to membrane surfaces to form the replication complex (Komoda et al., 2007) . Another fraction of tobamovirus replication proteins stays in the cytosol and binds small RNA duplexes to suppress RNA silencing (Hagiwara-Komoda et al., 2008; Ishibashi et al., 2011; Kurihara et al., 2007) . The functional differentiation occurs during and/or immediately after translation by as yet unknown mechanisms (Komoda et al., 2007) .
Replication of positive-strand RNA viruses depends not only on viral replication proteins but also on host factors. To date, hundreds of host factors involved in RNA replication of positive-strand RNA viruses have been identified (Krishnan et al., 2008; Kushner et al., 2003; Panavas et al., 2005; Sessions et al., 2009) , and for several factors, the functions in viral RNA replication have been revealed (Nagy and Pogany, 2011) . However, for the rest of the factors, detailed analyses are under way. Previously, we showed that a host transmembrane protein, TOM1, and a small GTP-binding protein, ARL8, are necessary for tobamovirus RNA replication (Nishikiori et al., 2011; Yamanaka et al., 2000) . TOM1, ARL8, and the helicase-domain polypeptide of tobamovirus replication proteins interact with each other in yeast, and ARL8 is associated with TOM1 and ToMV replication proteins that are active in RNA synthesis in infected plant cells (Nishikiori et al., 2011 Yamanaka et al., 2000) . In yeast, the 130K protein acquires the RNA 5 0 -capping-related functions when it is co-expressed with TOM1 and ARL8 (Nishikiori et al., 2011) . Thus, TOM1 and ARL8 play crucial roles in the activation of replication-related functions of tobamovirus replication proteins on membranes and are likely to be components of tobamovirus replication complex.
In this study, we found that guanylylation-competent ToMV replication proteins are in membrane-bound, disulfide-linked complexes. We further analyzed the phenotype of ToMV mutants which encode the replication proteins with each of the cysteine residues replaced by a serine residue to investigate the roles of disulfide bonding in the functioning of ToMV replication proteins.
Results

Guanylylation-competent ToMV replication proteins are in disulfidelinked complexes
In previous biochemical analyses of the replication of tobamovirus and other (þ)RNA viruses, reducing agents (e.g., b-mercaptoethanol Extracts of ToMV-180FS-GFP-infected and evacuolated tobacco BY-2 protoplasts [iBYL (Nishikiori et al., 2006) ] were subjected to centrifugation at 15,000 Â g to obtain supernatant (S15: ''S'' in the figure) and pellet (P15: ''P'' in the figure) fractions. iBYL S15 and P15 fractions were incubated with [a-32 P]GTP and AdoMet at 25 1C for 30 min, and analyzed by non-reducing and reducing 3-8% SDS-PAGE and autoradiography. The asterisk represents a guanylylated putative capping enzyme of the host. The positions of marker proteins are shown on the left with molecular masses. (C) Effect of DTT treatment on the electrophoretic mobility of ToMV replication proteins. Aliquots of the iBYL S15 and P15 fractions were subjected to non-reducing and reducing 3-8% SDS-PAGE, followed by immunoblotting with antibodies against ToMV replication proteins. The bracket indicates the disulfide-linked replication protein complexes. (D) Effect of DTT treatment on the electrophoretic mobility of cellular proteins. Cellular proteins were detected by Coomassie brilliant blue staining of the blotted membranes. (E) Analysis of the guanylylated proteins in the disulfide-linked, high-molecular-weight complexes. iBYL P15 fraction was incubated with [a-32 P]GTP and AdoMet at 25 1C for 30 min, and subjected to non-reducing 3-8% SDS-PAGE (left panel). 32 P-labeled proteins were recovered from the gel region boxed by the dotted line, treated with 100 mM DTT, and then subjected to reducing SDS-PAGE (right panel). and dithiothreitol [DTT]) were added to reaction mixtures to mimic the redox state of the cytoplasm where RNA replication takes place (Merits et al., 1999; Nishikiori et al., 2006; Buck, 1996, 1997; Watanabe et al., 1999) . We accidentally performed an in vitro guanylylation reaction with ToMV replication proteins prepared in the absence of reducing agents, and found that guanylylated replication proteins migrated very slowly in non-reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
To confirm this observation, we prepared extracts of ToMV-180FS-GFP-infected ( Fig. 1A) , evacuolated tobacco BY-2 protoplasts [iBYL, (Nishikiori et al., 2006 (Nishikiori et al., , 2011 ] without adding reducing agents, and fractionated them by centrifugation at 15,000 Â g into supernatant (S15) and membrane-rich pellet (P15) fractions. Each fraction was incubated with [a-32 P]GTP and AdoMet, and 32 P-labeled proteins were analyzed by SDS-PAGE. When the P15 sample for SDS-PAGE was treated with DTT, bands were detected at positions expected from their molecular masses of the ToMV 130K and FLAG-StrepII-tagged 180K (180K-FS) proteins (130 kDa and 180 kDa, respectively) ( Fig. 1B, left panel) . In the S15 sample, 32 Plabeled replication proteins were not detected. Instead, a cellular protein of about 70 kDa was detected ( Fig. 1B , left panel). This band may represent the cellular capping enzyme that also forms a covalent complex with guanylate (Shuman, 2002) .
The protein samples were next analyzed by SDS-PAGE without DTT treatment. Denaturation of proteins (e.g., with SDS) in the absence of reducing agents often cause the formation of unexpected disulfide bonds. Therefore, to prevent post-denaturation formation of disulfide bonds, the samples were treated with N-ethylmaleimide, which blocks free sulfhydryl groups, followed by addition of 2% SDS and incubation at 40 1C for 10 min. In the P15 sample, 32 P-labeled bands were not detected at positions expected for 130-kDa and 180-kDa proteins, but rather near the origin of electrophoresis ( Fig. 1B, right panel) . A band was also detected near the origin of electrophoresis even when samples were heated to 100 1C or treated with 10% trichloroacetic acid or 4% SDS. When 32 P-labeled proteins recovered from the uppermost part of the non-reducing gel were treated with DTT followed by separation using SDS-PAGE, bands appeared at positions expected for 130-kDa and 180-kDa proteins (Fig. 1E ). In the S15 fraction that was not treated with DTT, the 130K and 180K-FS proteins showed a similar separation pattern on immunoblots as found for the DTT-treated S15 sample (Fig. 1C ). In the P15 fraction that was not treated with DTT, slowly migrating smear bands of 130K and/or 180K-FS proteins (Fig. 1C , right panel, indicated by a bracket), which disappeared when the sample was treated with DTT, were detected on immunoblots (Fig. 1C , left panel). Note that DTT treatment did not alter the migration pattern of a putative cellular capping enzyme (the 32 P-labeled protein of about 70 kDa) ( Fig. 1B ) and most other cellular proteins (Fig. 1D ). These results suggest that a minor fraction of membrane-bound ToMV replication proteins exists in disulfide-linked complexes, and that guanylylation-competent replication proteins exist in the complexes.
Effects of reduction on the guanylylation competence of ToMV replication proteins
To clarify whether reduction of disulfide bonds decreases the guanylylation activity of ToMV replication proteins or dissociates the complexes, iBYL membrane proteins were solubilized by a detergent (lysophosphatidylcholine [LPC]), fractionated by sucrose gradient centrifugation in the presence or absence of DTT, and then assayed for guanylylation activity. Solubilization by LPC did not significantly affect the guanylylation activity of ToMV replication proteins. When DTT was not added during solubilization and fractionation, guanylylation of ToMV replication proteins occurred at a similar level to that observed for the sample prepared in the presence of DTT (compare Fig. 2B with C). Guanylylation-competent replication proteins were mainly recovered in fraction 2 ( Fig. 2C ). When analyzed by SDS-PAGE in the presence and absence of DTT, they migrated to the position expected from their molecular masses and remained near the origin of electrophoresis, respectively ( Fig. 2C and E). Replication proteins that were not disulfide-linked and 80S ribosomes were in fractions 1 and 3, respectively ( Fig. 2G and I) (Nishikiori et al., 2006) . When DTT was added during solubilization and fractionation, the electrophoresis pattern of the replication proteins was not changed by additional DTT treatment (100 mM) prior to SDS-PAGE (compare Fig. 2B with D or Fig. 2F with H), indicating that the disulfide bonds were fully reduced during solubilization and fractionation. Nevertheless, replication proteins maintained guanylylation competence, and guanylylation-competent replication proteins were mainly recovered in fraction 2 ( Fig. 2B and D) . These results suggest that reduction of disulfide bonds neither affects the activity of ToMV replication proteins to be guanylylated nor dissociates the replication protein-containing complexes. Note that exogenous templatedependent RdRp activity was also fractionated in fraction 2 in this condition (Nishikiori et al., 2006) .
Guanylylation competence of ToMV replication proteins synthesized by in vitro translation is increased by the addition of host membranes
ToMV replication proteins bind to the genomic RNA to form a premembrane-targeting complex (PMTC), and then are targeted to membranes to form the replication complex (Komoda et al., 2007) . To investigate whether ToMV replication proteins in the PMTC are competent for guanylylation, we used an in vitro ToMV RNA translation and replication system using extracts of evacuolated tobacco BY-2 protoplasts (BYL) (Komoda et al., 2007 (Komoda et al., , 2004 . BYL preparations and the following translation and replication reactions were performed without adding reducing agents (DTT was added to 2 mM throughout in the original protocol). Omission of DTT had little effect on the production of ToMV replication proteins and double-stranded ToMV RNA (replicative form [RF]) (positive-strand RNA synthesis was affected). Because the BYL translation mixture contained a high concentration of GTP, the specific activity of [a-32 P]GTP added to the BYL-based mixtures upon guanylylation assays was lower than expected. To circumvent this problem, we utilized TL130FS RNA, which encodes C-terminally FLAG-StrepII-tagged 130K protein (130K-FS: Fig. 3A ). TL130FS RNA was translated in membranedepleted BYL (mdBYL), and the reaction mixture was fractionated by centrifugation at 100,000 Â g into the supernatant (S100) and pellet (P100) fractions. The P100 fraction contained core PMTC [a PMTC-like complex that lacks the 180K protein (Komoda et al., 2007) ]. The 130K-FS protein was immunopurified from these fractions with anti-FLAG antibody to remove GTP, incubated with [a-32 P]GTP and AdoMet, and 32 P-labeled 130K-FS protein was analyzed by SDS-PAGE with or without DTT treatment ( Fig. 3B and C, ''membranes -'' lanes). In addition, to examine the effect of adding host membranes on guanylylation activity, 130K-FS proteins purified from the S100 and P100 fractions were incubated with BYL membranes and then subjected to the guanylylation assay ( Fig. 3B and C, ''membranes þ''). When samples were treated with DTT prior to SDS-PAGE, 32 P-labeled bands were detected at the position expected for a 130-kDa protein. This band was apparent in membrane-added 130K-FS from the P100 fraction and more weakly in membrane-added 130K-FS from the S100 fraction (Fig. 3B, lanes 6 and 8) . A very faint signal was observed at the same position in 130K-FS from the P100 fraction without membranes, but not in that from the S100 fraction without membranes (Fig. 3B, lanes 2 and 4) . Immunoblot analysis showed that these samples contained similar amounts of the 130K-FS protein (Fig. 3D) . Thus, the competence of 130K-FS for guanylylation was enhanced by the addition of membranes. When SDS-PAGE samples were not treated with DTT, 32 P-labeled bands were not detected at the position expected for a 130-kDa protein. Instead, signals stronger than those observed for mock-translated samples were detected near the origin of electrophoresis (Fig. 3C , compare lanes 6 and 8 with lanes 5 and 7, respectively). DTT-sensitive, slowly migrating smear bands of 130K-FS from the S100 and P100 fractions were detected on immunoblots (Fig. 3E) . These results suggest that guanylylation competence of ToMV replication protein in either soluble or PMTC fractions is enhanced via interactions with membranes. Importantly, guanylylation-competent replication proteins were contained in disulfide-linked complexes in both cases.
Guanylylation-competent ToMV 130K protein in yeast co-expressing TOM1 and ARL8 is also in disulfide-linked complexes Host transmembrane protein TOM1 and small GTP-binding protein ARL8 are required for ToMV RNA replication. In the yeast The effect of addition of membranes on guanylylation activity. TL130FS RNAtranslated mdBYL reaction mixture was fractionated by centrifugation at 100,000 Â g to obtain S100 and P100 fractions (indicated by S and P in the figure, respectively). 130K-FS was immunopurified from the S100 and P100 fractions with anti-FLAG antibody, and the purified proteins were incubated with or without membranes derived from BYL at 15 1C for 1 h (Komoda et al., 2007) . Each mixture was subjected to protein guanylylation assay ((B) and (C)) and immunoblotting ((D) and (E)). SDS-PAGE was performed under reducing ((B) and (D)) or non-reducing ((C) and (E)) conditions. The bracket indicates the intermolecularly disulfide-linked replication protein complexes.
Saccharomyces cerevisiae, which does not have TOM1 or ARL8 homologs, the ToMV 130K protein does not add a 5 0 -cap on RNA and it is not guanylylated if expressed alone. However, simultaneous co-expression of TOM1 and ARL8 activates guanylylation and RNA 5 0 -capping activities (Nishikiori et al., 2011) . Co-expression of TOM1 alone slightly enhances guanylylation activity, but ARL8 alone does not (Nishikiori et al., 2011) . Co-expression of TOM1 with or without ARL8 also enhances membrane association of the 130K protein (Nishikiori et al., 2011) . To examine whether guanylylationcompetent ToMV 130K protein purified from yeast is also in disulfide-linked complexes, 130K-FS was expressed alone or with TOM1 and/or ARL8 in yeast. 130K-FS was solubilized from membrane fractions of yeast cell extracts, subjected to immunopurification with anti-FLAG antibody, incubated with [a-32 P]GTP and AdoMet, and analyzed by non-reducing SDS-PAGE. 32 P-labeled protein was detected near the origin of electrophoresis in samples from yeast co-expressing either TOM1 alone or TOM1 plus ARL8 ( Fig. 4B) . A 130-kDa band was observed when the samples for SDS-PAGE were treated with DTT ( Fig. 4A ). Immunoblot analysis showed that the amount of disulfide-linked 130K-FS protein was increased by the co-expression of TOM1, and more strongly by that of TOM1 and ARL8 (compare Fig. 4D with C) . These results indicate that TOM1 facilitates formation of guanylylation-competent ToMV 130K protein that exists in the disulfide-linked complexes and that ARL8 enhances the effect of TOM1.
Effects of cysteine-to-serine substitutions in ToMV 130K protein on membrane association and guanylylation competence
To gain further insight into how formation of disulfide-linked complexes influence guanylylation competence in ToMV 130K protein, a series of ToMV mutants were constructed that encode the 130K protein in which each cysteine residue (-CH 2 -SH) was replaced with a serine residue (-CH 2 -OH) (Fig. 5A ). We translated mutant ToMV RNAs in BYL (containing membranes), fractionated the reaction mixture into the S15 (soluble) and P15 (membrane) fractions, and examined amounts and disulfide-linking status of the replication proteins by immunoblotting after SDS-PAGE under reducing and non-reducing conditions ( Fig. 5B to F). For C126S (2), C179S (3), C186S (4), C225S (6), and C581S (11) mutants, the amount of replication proteins in the P15 fraction was lower than that in the S15 fraction ( Fig. 5C and E Fig. 5D and F, indicated by brackets) . For wild-type and the other mutants, the amount of replication proteins in the P15 fraction was higher than in the S15 fraction ( Fig. 5C and E) , and DTT-sensitive signals with low electrophoretic mobility were observed in P15 and more faintly in S15 ( Fig. 5D and F, indicated by brackets) .
Next, we added [a-32 P]GTP and AdoMet to the P15 fractions and 32 P-labeled proteins were analyzed by SDS-PAGE ( Fig. 5G and  H) . As expected from the amount of replication proteins in the P15 fractions, bands were not detected for C179S (3), C186S (4), and C581S (11) mutants, and only faint signals were observed for C126S (2) and C225S (6) mutants.
Last, we examined the activity of RNA synthesis by adding [a-32 P]CTP and other ribonucleoside triphosphates to the P15 fractions. For C179S (3), C186S (4), and C581S (11) mutants, RNA replication was not detected (Fig. 5I ). For C126S (2), C225S (6), C282S (8), C837S (14), and C969S (18) mutants, low levels of RNA synthesis were observed. Some mutants (e.g., C250S [7] and C693S [12] ) synthesized viral RNA more efficiently than wild-type ToMV (Fig. 5I ).
Effects of ToMV 130K protein cysteine-to-serine substitutions on premembrane-targeting complex formation
The above results suggest that C179S, C186S, and C581S mutant replication proteins are defective in membrane binding. Because PMTC formation precedes membrane binding in the course of replication complex formation, we examined whether C179S, C186S, and C581S mutants can form the PMTC. Wild-type and mutant ToMV RNAs were translated in mdBYL and fractionated by sucrose gradient centrifugation under non-reducing conditions (Fig. 6A) . For wild-type ToMV, larger amounts of the replication proteins were detected in fractions 1 and 3 than in the other fractions, and the largest amount of the genomic RNA was found in fraction 3 (Fig. 6B) . Most of the wild-type ToMV replication proteins in fraction 3 formed complexes that migrated slowly in non-reducing SDS-PAGE and that disappeared after DTT treatment (Fig. 6B , compare the -DTT panel with the þDTT panel). Note that the PMTC that was formed in the presence of DTT and that contained ToMV RNA and the replication proteins was fractionated in fraction 3 of the sucrose gradient (Komoda et al., 2007) . In contrast, figure) were treated with 1% LPC and subjected to immunopurification with anti-FLAG antibody. The protein samples were prepared so that the concentration of the replication proteins was similar (samples for lanes 1 and 6 were prepared and analyzed in the same way as for those for lanes 2 and 7, respectively). The protein samples were then subjected to protein guanylylation assay ((A) and (B)) and immunoblotting using antibodies against ToMV replication proteins ((C) and (D)). SDS-PAGE was performed under reducing ((A) and (C)) or non-reducing ((B) and (D)) conditions. most of the replication proteins of the C179S, C186S, and C581S mutants remained in fraction 1 (the loading layer), while the genomic RNAs of these mutant ToMV were fractionated in fraction 3 (Fig. 6B) . Consistently, FLAG-tagged wild-type 130K protein synthesized in mdBYL co-immunoprecipitated the viral RNA, whereas FLAG-tagged C179S, C186S, or C581S mutant 130K proteins did not (Fig. 6C) . These results indicate that the mutants cannot form the PMTC. Next, we examined whether the C179S, C186S, and C581S mutant replication proteins are active in other functions. The soluble form of ToMV replication proteins has the ability to bind siRNA duplexes. This function contributes to the suppression of The genomic RNAs of wild-type (wt) and mutant ToMV were translated by using BYL at 25 1C for 60 min. ''-'' indicates mock translation. The translation mixtures were subjected to centrifugation at 15,000 Â g to obtain the supernatant (S15: (C) and (D)) and pellet (P15: (E) and (F)) fractions. Aliquots of the S15 and P15 fractions were subjected to reducing ((C) and (E)) and non-reducing ((D) and (F)) PAGE, followed by immunoblotting using antibodies against ToMV replication proteins. The brackets indicate the intermolecularly disulfide-linked replication protein complexes. Unfractionated translation mixtures were also analyzed by reducing PAGE/immunoblotting (B). ((G)-(I)) Effects of cysteine-to-serine mutations on the replication-related functions of ToMV replication proteins. Aliquots of the P15 membrane fractions were incubated with [a-32 P]GTP and AdoMet and subjected to reducing (G) and non-reducing (H) PAGE to detect protein guanylation activity, or with [a-32 P]CTP and other ribonucleoside triphosphates to detect RdRp activity (I). RNA products of the RdRp assay were treated with a single-strand-specific S1 nuclease and analyzed by 8 M urea-2.4% PAGE followed by autoradiography. RF indicates the replicative form RNA.
RNA silencing (Hagiwara-Komoda et al., 2008; Kurihara et al., 2007) . To examine this activity, mutant replication proteins were synthesized in mdBYL, and S100 fractions were prepared. Consistent with the results shown in Fig. 5B , accumulated levels of C179S, C186S, and C581S mutant replication proteins in the S100 fractions (soluble replication proteins) were higher than those of the wild type (Fig. 6D ). Then the S100 fractions were incubated with a 32 Plabeled 22-nt RNA duplex and subjected to an electrophoretic mobility shift assay. Mutant replication proteins bound the small RNA duplex at similar or even higher efficiency compared to the wild-type replication proteins (Fig. 6D) . Previously, we found that a ToMV RNA derivative that encodes only a 130K protein and is unable to replicate by itself (TL130; Fig. 6E ) can replicate if soluble 180K protein is supplied in trans (Komoda et al., 2007) . To examine the effects of C179S, C186S, and C581S mutations on this 180K protein activity, we translated TL130 RNA (wild-type) in mdBYL, mixed with soluble 180K protein carrying these mutations (the S100 fractions of mdBYL in which TL180D3 0 -type mRNAs (Fig. 6E) were translated). The reactions were further incubated with BYL membranes and 32 P-labeled ribonucleoside triphosphates. TL130 RNA replicated (i.e., synthesized the RF RNA) with the aid of the 180K proteins carrying the C179S, C186S, and C581S mutations, as well as with the aid of wildtype 180K protein (Fig. 6E) . These results indicate that the C179S, C186S, and C581S mutations specifically affect PMTC formation, while retaining the ability to bind siRNA duplexes and support viral RNA replication in trans.
Guanylylation-competent replication proteins of other positivestrand RNA viruses are also in disulfide-linked complexes Alignment of the amino acid sequences of the methyltransferase domain of alpha-like viruses revealed that two cysteine residues (C179 and C186 in ToMV) are conserved (Rozanov et al., 1992) (Fig. 7A) , and mutations in these residues result in the loss of viral multiplication and/or capping-related functions [Alfalfa mosaic virus 1a (Vlot et al., 2002) , BMV 1a (Yi and Kao, 2008) , and Semliki forest virus nsP1 (Ahola et al., 1997) ]. Thus, we hypothesized that our finding with ToMV might apply to other alpha-like viruses. To test this possibility, we examined whether guanylylation-competent Wild-type (wt) and mutant ToMV RNAs were translated using mdBYL at 25 1C for 60 min, and the translation mixtures were loaded onto 15-40% (wt/vol) sucrose gradients that did not contain DTT and subjected to centrifugation. Each gradient was manually fractionated into five fractions (numbered 1-5, from top to bottom). (B) Effects of the cysteine-to-serine mutations on PMTC formation. Aliquots of the five fractions were subjected to reducing (upper panels) and non-reducing (middle panels) SDS-PAGE, followed by immunoblotting with antibodies against ToMV replication proteins. RNA was extracted from aliquots of the five fractions and analyzed by Northern blot hybridization using a 32 P-labeled P1M RNA probe that was complementary to ToMV genomic RNA (Ishikawa et al., 1991) . (C) Effects of the cysteine-to-serine mutations on binding of the replication proteins to ToMV RNA. 32 P-labeled wild-type and mutant TL130FS RNAs were generated by in vitro transcription and translated in mdBYL. 130K-FS proteins were immunopurified from the translation mixture with anti-FLAG antibody (Komoda et al., 2007) . In the lane marked ''w/o trn'', puromycin was added to the reaction mixture before the translation reaction was started. Co-purified RNA was extracted and analyzed with PAGE and autoradiography (lower panel). 130K-FS protein in the purified fractions was detected by immunoblotting with antibodies against ToMV replication proteins (upper panel). (D) Effects of the cysteine-to-serine mutations on binding of the replication proteins to a small RNA duplex. The S100 fractions of wild-type or mutant ToMV RNAtranslated, or mock-translated mdBYL were incubated with a 32 P-labeled 22-nt RNA duplex and analyzed with 4% native PAGE (lower panel) (Iki et al., 2010) . ToMV replication proteins in the mdBYL S100 fractions were detected by immunoblotting with antibodies against ToMV replication proteins (upper panel). (E) Effects of the cysteine-to-serine mutations on the ability of the 180K protein to trans-complement TL130 RNA replication. The structures of TL130 and TL180D3 0 RNAs are shown. The P100 fractions were prepared from TL130-translated or mock-translated mdBYL, then mixed with the S100 fractions from TL180D3 0 (with or without mutations)translated or mock-translated mdBYL as indicated in the figure. Each mixture was mixed with P30 BYL membrane fractions, puromycin, ATP, creatine kinase and creatine phosphate, and then subjected to RdRp assay as indicated in the legend of Fig. 5 (middle panel) and immunoblotting with antibodies against ToMV replication proteins (lower panel). RF indicates the replicative form RNA.
replication proteins of BMV and CMV are contained in SDS-resistant, DTT-sensitive complexes. We inoculated tobacco BY-2 protoplasts with BMV, CMV, and ToMV RNAs, prepared S15 and P15 fractions from the extracts of the inoculated protoplasts without DTT, and then incubated the fractions with [a-32 P]GTP and AdoMet. The samples were analyzed by reducing or non-reducing SDS-PAGE. In reducing SDS-PAGE, infection-specific 32 P-labeled bands were observed in P15 samples where BMV 1a, CMV 1a, or ToMV 130K proteins migrate (100-130 kDa) ( Fig. 7B to D) . In contrast, in non-reducing SDS-PAGE, the 32 P-labeled bands were observed near the origin of gel electrophoresis ( Fig. 7B to D) . In protoplasts that were infected with ToMV by electroporation, most of the soluble ToMV replication proteins formed complexes that remained near the origin of non-reducing SDS-PAGE (Fig. 7B ). This was in contrast to experiments using plant cells where ToMV infection was induced by estradiol ( Fig. 1 ). This may have been due to the oxidative status in plant cells induced during preparation and the culture of protoplasts (Pineiro et al., 1994) . These results indicate that guanylylation-competent replication proteins of BMV and CMV are also in disulfide-linked complexes.
Discussion
We found that a minor fraction of membrane-bound ToMV replication proteins in estradiol-induced ToMV-infected cells migrated in non-reducing SDS-PAGE near the origin of electrophoresis, and that guanylylation-competent replication proteins were in this minor fraction (Fig. 1) . After solubilization with a detergent, guanylylation-competent replication proteins sedimented through a sucrose gradient into the second fraction, while most non-disulfide-linked ToMV replication proteins and 80S ribosomes were fractionated to the first (topmost) and third fractions, respectively (Fig. 2) (Nishikiori et al., 2006) . These results suggest that guanylylation-competent ToMV replication proteins are in intermolecularly disulfide-linked, high-molecularweight complexes. However, the composition and other details of the complexes remain to be determined.
In eukaryotic cells, protein disulfide bonds are mostly formed in the ER lumen or mitochondrial intermembrane space. These locations provide an oxidizing environment. Cytosolic proteins are rarely disulfide-linked (Riemer et al., 2009 ). Nevertheless, a few cytosolic proteins do form intermolecular disulfide bonds (Locker and Griffiths, 1999; Mou et al., 2003) , and this study provides an additional example.
To investigate the significance of disulfide bond formation in ToMV replication proteins in the activation of guanylylation activity, we examined the phenotypes of ToMV mutants that carry the 130K protein with cysteine-to-serine substitutions. Replication proteins with C179S, C186S, or C581S substitutions exhibited pleiotropic defects in forming the PMTC, binding to membranes, gaining guanylyltransferase activity, and forming disulfide-linked complexes (Fig. 5) . In contrast, the 180K protein with C179S, C186S, or C581S substitutions acquired RdRp activity when they were mixed with membranes and the core PMTC that was formed by the ToMV variant expressing only the 130K protein (Fig. 6 ). This suggests that the 180K protein can be recruited to the replication complex through molecular interactions that are not affected by these mutations. Therefore, these mutations unlikely affect overall structure of the replication proteins.
What is the direct consequence of C179S, C186S, and C581S substitutions on ToMV replication proteins? The earliest step, i.e., PMTC formation should be directly affected by the mutations (Fig. 6 ). PMTC is targeted to membrane surfaces to form the ToMV replication complex (Komoda et al., 2007) . Therefore, the inability of the mutant replication proteins to bind to membranes would be attributable in part to the inability of PMTC formation. On the other hand, the replication proteins in the S100 fraction of wildtype ToMV RNA-translated mdBYL showed guanylylation activity , CMV (C), and BMV (D) RNAs were fractionated by centrifugation at 15,000 Â g to obtain S15 and P15 fractions (indicated by S and P in the figure, respectively). The S15 and P15 fractions were incubated with [a-32 P]GTP and AdoMet, and analyzed by non-reducing and reducing SDS-PAGE followed by autoradiography (upper panels). The fractions were also subjected to non-reducing and reducing 3-8% SDS-PAGE followed by immunoblotting with antibodies against each replication protein (lower panels). when mixed with membranes ( Fig. 3 ). This suggests that ToMV replication proteins can bind to membranes without PMTC formation, and that the mutant replication proteins cannot bind to membranes also via this pathway. It is known that cysteine residues can be S-palmitoylated and this modification can be involved in membrane binding, however, the cysteine residues in the 130K protein have not been predicted nor experimentally shown to be S-palmitoylated. The lack of guanylylation activity was likely due to the inability of the replication proteins to bind to membranes because guanylylation activity in ToMV replication proteins was only detected in the membrane fraction (Fig. 1) , and because the replication proteins synthesized in the absence of membranes had little guanylylation activity unless mixed with membranes ( Fig. 3) .
Considering that the ToMV PMTC and RNA replication complex can form in DTT-containing BYL (Komoda et al., 2007 (Komoda et al., , 2004 , disulfide bond formation itself is unlikely to be essential for PMTC formation and membrane binding. Rather, we presume that PMTC formation and membrane binding require non-covalent intermolecular interactions involving cysteine residues in the replication proteins. One possibility is that a sulfhydryl group of a cysteine residue in a ToMV replication protein is placed in close vicinity to that in another protein (perhaps another replication protein), and they form disulfide bonds when the residues are placed in an oxidizing environment, e.g., in a membrane-surrounded replication complex compartment or in vitro reaction mixtures without DTT.
In yeast, the 130K replication protein expressed alone had some membrane binding activity, but did not have guanylyltransferase activity. It was also not efficiently disulfide-linked. In contrast, when the 130K replication protein was co-expressed with TOM1 and ARL8 in yeast, it bound to membranes more efficiently, had guanylyltransferase activity, and was disulfide-linked ( Fig. 4) . Thus, one of the roles of TOM1 and ARL8 in ToMV RNA replication might be to provide the membrane-bound replication proteins with an oxidizing environment, which leads to the formation of disulfide bonds and activation of guanylyltransferase activity. Alternatively, TOM1 and ARL8 may modify the conformation of the replication proteins to be more suitable for disulfide bond formation and the enzymatic activation. Under this hypothesis, because reduction of disulfide bonds with DTT in solubilized ToMV replication proteins prepared from the membranes of ToMV-infected plant cells did not affect guanylylation activity (Fig. 2) , once the replication proteins gain the activity, disulfide bonds are no longer required for maintenance of the activity.
The 179th and 186th cysteine residues in ToMV replication proteins are conserved in the replication proteins of many alphalike positive-strand RNA viruses. For some viruses, they are important for capping-related functions and replication (Ahola et al., 2000 (Ahola et al., , 1997 Rozanov et al., 1992) . In this study, we found that guanylylation-competent BMV and CMV 1a replication proteins are also found in membrane-bound, disulfide-linked complexes (Fig. 7) . These results may highlight the evolutionary conservation of common mechanisms for enzymatic activation of replication proteins and importance of the replication protein disulfide bonding in the replication of alpha-like viruses.
The BMV replication complexes consists of membranous invaginations called spherules and/or multilayered membrane stacks (Ahlquist, 2006; den Boon and Ahlquist, 2010; den Boon et al., 2010) . A spherule is 50-100 nm in diameter and each contains approximately 200-400 1a proteins, 10-20 2a proteins, and a few positive-and negative-strand RNA molecules (Schwartz et al., 2002) . The methyltransferase (capping) domain polypeptide of BMV 1a forms extended, stacked, hexagonal lattices, possibly through multiple intermolecular interactions. The helicase domain polypeptide can also self-associate (Diaz et al., 2012) . The formation of spherular BMV replication complexes depends on direct linkages and concerted action of the self-interacting methyltransferase and helicase domains. Likewise, the helicase-like domain-containing fragments of TMV 130K protein have the ability to self-interact and form ring-like hexamers (Goregaoker and Culver, 2003; Goregaoker et al., 2001) . In ToMV, BMV, and CMV, intermolecular disulfide bonds may contribute to the stabilization of such lattices. Further studies are required to test this hypothesis.
Materials and methods
Preparation of yeast and plant cell extracts
A transgenic Nicotiana tabacum BY-2 cell line RT4 was used, in which infection with a ToMV derivative that encodes the 130K and FLAG-StrepII-tagged 180K (180K-FS) proteins can be induced by treatment with estradiol (Nishikiori et al., 2006) (Figs. 1, 2 and  4) . A protease-deficient yeast strain BJ5465 was used for the expression of TOM1, ARL8, and FLAG-StrepII-tagged 130K protein (130K-FS) (Nishikiori et al., 2011) (Fig. 4) . Inoculation of tobacco BY-2 protoplasts with viral RNA by electroporation was described previously (Ishikawa et al., 1993; Watanabe et al., 1987) (Fig. 7) . The cell extracts of virus-infected evacuolated BY-2 protoplasts [iBYL (Nishikiori et al., 2006) ] and yeast spheroplasts were prepared as described previously using a hypotonic buffer (10 mM Tris-HCl [pH 8], 10 mM EDTA with one tablet of Complete Mini protease inhibitor [Roche] per 10 ml) (Nishikiori et al., 2011) .
In vitro translation and replication
Mutations were introduced by the overlap PCR method into pTLW3(Sma) (Komoda et al., 2007) to alter the sequences encoding each of the 19 cysteine residues in ToMV 130K protein. Wild-type and mutant RNAs were synthesized in vitro by an AmpliCap-Max T7 transcription kit (Cellscript). Evacuolated BY-2 protoplast extracts (BYL) and membrane-depleted BYL (mdBYL) were prepared as described previously (Komoda et al., 2007 (Komoda et al., , 2004 , except that DTT was omitted from the TR buffer (30 mM Hepes-KOH [pH 7.4], 80 mM KOAc, 1.8 mM MgOAc, and one tablet of Complete protease inhibitor per 10 ml). Wild-type and mutant ToMV RNAs (1.2 mg) were translated in 60-ml reaction mixtures at 25 1C for 60 min. Protein guanylylation and RdRp assays were performed as described previously (Komoda et al., 2004; Nishikiori et al., 2011) , except that DTT and RNase inhibitor were omitted from the reaction mixtures.
SDS-PAGE and immunoblotting
SDS-PAGE was performed using NuPAGE 3-8% Tris-acetate gels (Invitrogen). Protein samples for SDS-PAGE were treated with N-ethylmaleimide (final 12.5 mM) at 4 1C for 10 min to avoid disulfide bond exchange reactions upon denaturation (Kono et al., 1998) , precipitated with 10% trichloroacetic acid, and dissolved in standard sample buffer with (final 100 mM) or without DTT. After SDS-PAGE, the gels were soaked in a DTT-containing transfer buffer (25 mM Tris, 190 mM glycine, 10 mM DTT) for 10 min at room temperature to facilitate electrotransfer of proteins in disulfide-linked complexes to the PVDF membrane. Antibodies against ToMV 130K and 180K, BMV 1a, and CMV 1a proteins were described previously (Hagiwara et al., 2003; Restrepo-Hartwig and Ahlquist, 1996; Yoshii et al., 2004) .
Sucrose gradient sedimentation analysis
Sucrose gradient sedimentation analysis in Fig. 2 was performed as described previously (Nishikiori et al., 2006) , except that GTP was omitted from solutions used for sample solubilization and fractionation. Briefly, P15 membranes from 67 ml iBYL were incubated at 15 1C for 20 min in 200 ml of NTR buffer (30 mM Hepes-KOH [pH 7.4], 80 mM KOAc, 1.8 mM MgOAc, 0.2 mM ATP and UTP, and one tablet of Complete mini protease inhibitor per 10 ml) containing 1% (wt/vol) lysophosphatidylcholine (LPC) with or without DTT (2 mM). The treated samples were loaded onto sucrose gradients (10-50% [wt/wt]) and subjected to centrifugation (100,000 Â g for 1 h at 4 1C) in a Beckman TLS-55 rotor. After centrifugation, the gradients were manually fractionated into eight fractions of 300 ml of each. Sucrose gradient sedimentation analysis in Fig. 6 was performed as described previously (Komoda et al., 2007) , except that DTT and RNase inhibitor were omitted from the BYL translation mixtures and sucrose gradient. Briefly, ToMV or mutant RNA (4 mg)-translated mdBYL reaction mixtures (200 ml) were loaded onto sucrose gradients (15-40% [wt/ vol]) and subjected to centrifugation (100,000 Â g for 2 h at 4 1C) in a Beckman TLS-55 rotor. After centrifugation, the gradients were manually fractionated into five fractions.
Immunoprecipitation of ToMV replication proteins
The ToMV 130K-FS protein was immunoprecipitated from mdBYL-based reaction mixtures (500 ml in Fig. 3 and 150 ml in Fig. 6 ) as described previously (Komoda et al., 2007) . Immunoprecipitation of 130K-FS and 180K-FS proteins from the extracts of yeast and plant cells was performed as described previously (Nishikiori et al., 2006 (Nishikiori et al., , 2011 , expect that DTT and GTP were omitted from solubilization buffer (30 mM Hepes-KOH [pH 7.4], 80 mM KOAc, 1.8 mM MgOAc, 0.2 mM ATP and UTP, 1% LPC, and one tablet of Complete mini protease inhibitor per 10 ml).
Small RNA duplex binding assay
The binding of ToMV replication proteins to a 22-nt RNA duplex was examined as described previously (Iki et al., 2010; Ishibashi et al., 2011) .
